Development of translational ILD models: How drug-induced side effects trigger alterations in the lung tissue upon systemical long-term exposure? (Conference Abstract)
Physiologically-based pharmacokinetic modelling of transporter-mediated hepatic disposition using the imaging biomarker gadoxetate (Conference Abstract)